Radiation Therapy and HL

The use of radiation therapy (RT) has been shown to improve 10-year survival rates in patients with stage I-II Hodgkin’s lymphoma (HL). However, the use of RT in this patient population declined from 56% to 41% between 1998 and 2011. 

When asked, physicians indicated that they did not use RT because it was not part of the planned treatment strategy. In this study, 41,502 patients who had been diagnosed with stage I-II HL were selected from the National Cancer Data Base. Among these patients, 96% (n = 39,842) had received chemotherapy and 49% (n =20,441) RT. Ten-year overall survival (OS) for all patients was 80.8%. Among those who received RT, the median OS rate was 84.4% compared with 76.4% who did not receive RT. For more information, click here.


Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe


Do you understand how cancer drugs are approved in your country?




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.